When San Francisco-based surgeon Dr. Anne Peled decided to undergo a sensation-preserving mastectomy following her second ...

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell ...

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

FDA Authorizes Device for Dialysis-Related Amyloidosis Researchers found no evidence of worse cancer outcomes with nerve-sparing surgery. Using a nerve-sparing technique that preserves the ...

Testosterone Modestly Improves Sexual Function in Older Men Men undergoing radical cystectomy are most likely to recover erectile function if they have good function before the surgery and receive ...

A research collaboration including scientists from Oregon State University has developed a new technology to help surgeons know where a patient's nerves are, lessening the chance of nerve damage. The ...

This promising new application for Remplir can potentially reduce post-surgical complications from peripheral nerve injury, representing a globally significant commercial opportunity for the Company.

PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell Limited (ASX: OCC) is pleased to announce adoption of Remplir™ by Australian urologists is accelerating with the product increasingly being ...